Trending

BeyondSpring

Cancer biotech BeyondSpring hit by weak IPO

Cancer biotech BeyondSpring hit by weak IPO

Hoping for $100m, biotech raises under $3.5 million on stock market

X

Cancer biotech BeyondSpring hit by weak IPO

https://pharmaphorum.com/news/cancer-drug-firm-beyondspring-downsizes-ipo/

BeyondSpring plans three-pronged attack on cancer

BeyondSpring plans three-pronged attack on cancer

The CEO of BeyondSpring said the company hopes to make its name with a new lung cancer drug

X

BeyondSpring plans three-pronged attack on cancer

https://pharmaphorum.com/news/chinas-beyondspring-plans-three-pronged-attack-cancer/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com